InvestorsObserver
×
News Home

Aprea Therapeutics Inc (APRE) Up 8.47% in Premarket Trading

Thursday, February 11, 2021 08:11 AM | InvestorsObserver Analysts

Mentioned in this article

Aprea Therapeutics Inc (APRE) Up 8.47% in Premarket Trading

Aprea Therapeutics Inc (Aprea Therapeutics Inc (APRE)) is higher by Thursday morning, with the stock climbing 8.47% in pre-market trading to 8.84.

APRE's short-term technical score of 2 indicates that the stock has traded less bullishly over the last month than 98% of stocks on the market. In the Biotechnology industry, which ranks 75 out of 146 industries, Aprea Therapeutics Inc ranks higher than 2% of stocks.

Aprea Therapeutics Inc has risen 55.53% over the past month, closing at $5.21 on January 14. During this period of time, the stock fell as low as $5.15 and as high as $8.30. APRE has an average analyst recommendation of Buy. The company has an average price target of $13.00.

Overall Score - 31
APRE has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on APRE!

Aprea Therapeutics Inc has a Long-Term Technical rank of 0. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 100% of the market scoring higher. In the Biotechnology industry which is number 55 by this metric, APRE ranks better than 0% of stocks.

Important Dates for Investors in APRE:

-Aprea Therapeutics Inc is set to release earnings on 3/25/2021. During their last earnings release the company posted EPS of $-5.70. -We do not have a set dividend date for Aprea Therapeutics Inc at this time. Click Here to get the full Stock Score Report on Aprea Therapeutics Inc (APRE) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App